Skip to main content
TipRanks
Go Ultimate75% OFF

Ajanta Pharma Limited (AJANTPHARM) Financial Statements

6 Followers

Ajanta Pharma Limited Financial Overview

Ajanta Pharma Limited's market cap is currently ₹410.42B. The company's EPS TTM is ₹101.08; its P/E ratio is 32.49; and it has a dividend yield of 1.83%. Ajanta Pharma Limited is estimated to report earnings on February 3, 2027, and the estimated EPS forecast is ₹23.70. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue₹ 54.53B₹ 45.88B₹ 41.62B₹ 37.08B₹ 32.84B
Gross Profit₹ 28.05B₹ 34.60B₹ 30.46B₹ 25.91B₹ 23.97B
Operating Income₹ 13.25B₹ 11.28B₹ 10.46B₹ 6.80B₹ 8.12B
EBITDA₹ 15.67B₹ 13.54B₹ 12.57B₹ 8.82B₹ 10.45B
Net Income₹ 10.56B₹ 9.20B₹ 8.16B₹ 5.88B₹ 7.13B
Balance Sheet
Cash & Short-Term Investments₹ 6.65B₹ 6.15B₹ 4.60B₹ 8.44B₹ 3.28B
Total Assets₹ 61.55B₹ 50.15B₹ 46.38B₹ 46.79B₹ 40.56B
Total Debt₹ 2.60B₹ 474.20M₹ 352.80M₹ 356.30M₹ 250.30M
Net Debt₹ 1.55B₹ -1.29B₹ -942.10M₹ -2.94B₹ -1.81B
Total Liabilities₹ 16.28B₹ 12.25B₹ 10.71B₹ 12.91B₹ 7.91B
Stockholders' Equity₹ 45.27B₹ 37.90B₹ 35.67B₹ 33.88B₹ 32.64B
Cash Flow
Free Cash Flow₹ 1.51B₹ 8.39B₹ 6.33B₹ 6.17B₹ 4.13B
Operating Cash Flow₹ 5.16B₹ 11.57B₹ 7.85B₹ 7.92B₹ 5.62B
Investing Cash Flow₹ -4.29B₹ -3.77B₹ 653.90M₹ -5.60B₹ -741.00M
Financing Cash Flow₹ -1.55B₹ -7.33B₹ -10.51B₹ -1.08B₹ -4.60B

Currency in INR

Ajanta Pharma Limited Earnings and Revenue History

020B40B60B15 %20 %25 %30 %EarningsProfit Margin2017201820192020202120222023202420252026RevenueEarningsProfit Margin

Ajanta Pharma Limited Liabilities to Assets

025B50B75B12 %18 %24 %30 %LiabilitiesLiabilities to Assets2017201820192020202120222023202420252026AssetsLiabilitiesLiabilities to Assets

Ajanta Pharma Limited Cash Flow

-15B-10B-5B05B10B15B2017201820192020202120222023202420252026OperatingInvestingFinancing

Ajanta Pharma Limited Forecast EPS vs Actual EPS

182022242628303234Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27EPS EstimateBeatMiss